• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较新的风险预测模型与前列腺癌风险计算器应用程序在台湾人群中的应用。

Comparing a new risk prediction model with prostate cancer risk calculator apps in a Taiwanese population.

机构信息

Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, 386 Ta-Chung 1st Rd., Zuoying, Kaohsiung, Taiwan.

School of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

World J Urol. 2021 Mar;39(3):797-802. doi: 10.1007/s00345-020-03256-2. Epub 2020 May 20.

DOI:10.1007/s00345-020-03256-2
PMID:32436074
Abstract

PURPOSE

To develop a novel Taiwanese prostate cancer (PCa) risk model for predicting PCa, comparing its predictive performance with that of two well-established PCa risk calculator apps.

METHODS

1545 men undergoing prostate biopsies in a Taiwanese tertiary medical center between 2012 and 2019 were identified retrospectively. A five-fold cross-validated logistic regression risk model was created to calculate the probabilities of PCa and high-grade PCa (Gleason score ≧ 7), to compare those of the Rotterdam and Coral apps. Discrimination was analyzed using the area under the receiver operator characteristic curve (AUC). Calibration was graphically evaluated with the goodness-of-fit test. Decision-curve analysis was performed for clinical utility. At different risk thresholds to biopsy, the proportion of biopsies saved versus low- and high-grade PCa missed were presented.

RESULTS

Overall, 278/1309 (21.2%) patients were diagnosed with PCa, and 181 out of 278 (65.1%) patients had high-grade PCa. Both our model and the Rotterdam app demonstrated better discriminative ability than the Coral app for detection of PCa (AUC: 0.795 vs 0.792 vs 0.697, DeLong's method: P < 0.001) and high-grade PCa (AUC: 0.869 vs 0.873 vs 0.767, P < 0.001). Using a ≥ 10% risk threshold for high-grade PCa to biopsy, our model could save 67.2% of total biopsies; among these saved biopsies, only 3.4% high-grade PCa would be missed.

CONCLUSION

Our new logistic regression model, similar to the Rotterdam app, outperformed the Coral app in the prediction of PCa and high-grade PCa. Additionally, our model could save unnecessary biopsies and avoid missing clinically significant PCa in the Taiwanese population.

摘要

目的

开发一种新的台湾前列腺癌(PCa)风险模型,以预测 PCa,并将其预测性能与两种成熟的 PCa 风险计算器应用程序进行比较。

方法

回顾性分析了 2012 年至 2019 年间在台湾一家三级医疗中心接受前列腺活检的 1545 名男性患者。建立了一个五折交叉验证逻辑回归风险模型,以计算 PCa 和高级别 PCa(Gleason 评分≧7)的概率,并与 Rotterdam 和 Coral 应用程序进行比较。使用接受者操作特征曲线下的面积(AUC)分析区分度。通过拟合优度检验图形评估校准。进行决策曲线分析以评估临床效用。在不同的活检风险阈值下,展示了活检减少量与低级别和高级别 PCa 漏诊量的比例。

结果

总体而言,1309 名患者中有 278 名(21.2%)被诊断为 PCa,278 名患者中有 181 名(65.1%)患有高级别 PCa。我们的模型和 Rotterdam 应用程序在检测 PCa 方面均优于 Coral 应用程序(AUC:0.795 比 0.792 比 0.697,DeLong 方法:P<0.001)和高级别 PCa(AUC:0.869 比 0.873 比 0.767,P<0.001)。使用高级别 PCa 活检的风险阈值≥10%,我们的模型可以减少 67.2%的总活检量;在这些减少的活检中,只有 3.4%的高级别 PCa 会被漏诊。

结论

我们的新逻辑回归模型与 Rotterdam 应用程序类似,在预测 PCa 和高级别 PCa 方面优于 Coral 应用程序。此外,我们的模型可以减少不必要的活检,并避免在台湾人群中漏诊有临床意义的 PCa。

相似文献

1
Comparing a new risk prediction model with prostate cancer risk calculator apps in a Taiwanese population.比较新的风险预测模型与前列腺癌风险计算器应用程序在台湾人群中的应用。
World J Urol. 2021 Mar;39(3):797-802. doi: 10.1007/s00345-020-03256-2. Epub 2020 May 20.
2
Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study.前列腺癌风险计算器应用程序在台湾人群队列中的应用:验证研究。
J Med Internet Res. 2020 Dec 18;22(12):e16322. doi: 10.2196/16322.
3
Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.通过纳入 2014 年国际泌尿病理学会格里森分级和筛状生长,改进用于初始前列腺活检的 Rotterdam 欧洲前列腺癌筛查风险计算器。
Eur Urol. 2017 Jul;72(1):45-51. doi: 10.1016/j.eururo.2017.01.033. Epub 2017 Feb 2.
4
Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation.鹿特丹手机应用程序,包括 MRI 数据,用于预测前列腺癌:多中心外部验证。
Eur J Surg Oncol. 2021 Oct;47(10):2640-2645. doi: 10.1016/j.ejso.2021.04.033. Epub 2021 Apr 30.
5
Mobile phone apps for the prediction of prostate cancer: External validation of the Coral and Rotterdam apps.手机应用程序预测前列腺癌:Coral 和 Rotterdam 应用程序的外部验证。
Eur J Surg Oncol. 2019 Mar;45(3):471-476. doi: 10.1016/j.ejso.2018.09.018. Epub 2018 Oct 16.
6
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.尿液中TMPRSS2:ERG加PCA3用于个体化前列腺癌风险评估。
Eur Urol. 2016 Jul;70(1):45-53. doi: 10.1016/j.eururo.2015.04.039. Epub 2015 May 16.
7
Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.在未经前列腺活检的患者中进行前列腺癌风险评估:多参数磁共振成像-经直肠超声(TRUS)融合活检和系统 TRUS 活检中的鹿特丹前列腺癌风险计算器。
Eur Urol Oncol. 2018 Jun;1(2):109-117. doi: 10.1016/j.euo.2018.02.010. Epub 2018 May 15.
8
Comparing the prediction of prostate biopsy outcome using the Chinese Prostate Cancer Consortium (CPCC) Risk Calculator and the Asian adapted Rotterdam European Randomized Study of Screening for Prostate Cancer (ERSPC) Risk Calculator in Chinese and European men.比较中国前列腺癌联盟(CPCC)风险计算器和亚洲改编版 Rotterdam 欧洲前列腺癌筛查随机研究(ERSPC)风险计算器在中、欧男性中的前列腺活检结果预测。
World J Urol. 2021 Jan;39(1):73-80. doi: 10.1007/s00345-020-03177-0. Epub 2020 Apr 11.
9
Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.基于风险的患者选择行 MRI 靶向前列腺活检可避免不必要的 MRI 扫描。此类患者为经直肠超声引导下前列腺随机活检阴性。
Eur Urol. 2016 Jun;69(6):1129-34. doi: 10.1016/j.eururo.2015.11.018. Epub 2015 Dec 2.
10
'Prostate Cancer Risk Calculator' mobile applications (Apps): a systematic review and scoring using the validated user version of the Mobile Application Rating Scale (uMARS).'前列腺癌风险计算器' 移动应用程序 (Apps):使用经过验证的移动应用程序评级量表 (uMARS) 的用户版本进行的系统评价和评分。
World J Urol. 2018 Apr;36(4):565-573. doi: 10.1007/s00345-017-2150-1. Epub 2017 Dec 8.

引用本文的文献

1
Risk calculators for the detection of prostate cancer: a systematic review.用于检测前列腺癌的风险计算器:一项系统综述。
Prostate Cancer Prostatic Dis. 2024 Sep;27(3):544-557. doi: 10.1038/s41391-024-00852-w. Epub 2024 Jun 3.
2
Prostate Cancer Risk Calculators for Healthy Populations: Systematic Review.健康人群前列腺癌风险计算器:系统评价
JMIR Cancer. 2021 Sep 3;7(3):e30430. doi: 10.2196/30430.

本文引用的文献

1
Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.前列腺癌风险模型是否能提高 PSA 筛查的预测准确性?一项荟萃分析。
Ann Oncol. 2015 May;26(5):848-864. doi: 10.1093/annonc/mdu525. Epub 2014 Nov 17.